PCR detection of Toxoplasma gondii DNA versus serological diagnosis in women suffering from repeated abortion by Abo EL Naga , AM
The Egyptian Journal of Hospital Medicine (2008) Vol., 33: 577– 586 
 
 
PCR detection of Toxoplasma gondii DNA versus serological diagnosis in 
women suffering from repeated abortion 
 
Abo EL Naga (1), AM; Shaltot (2), AA; Rizk EL- Baz(2),  
And Eman fayad(1). 
(1)Zoology Department, Faculty of Science at Mansoura University, Egypt. 
(2) Genetics unit, children Hospital, Mansoura University, Egypt. 
 
Abstract 
 
        Background: This study was conducted to test the utility of polymerase chain reaction 
(PCR) assay to detect recent infections with Toxoplasma in pregnant women. T.gondii DNA 
was detected by using B1 gene as a target for amplification which is highly specific for T.gondii 
and is well conserved among all of the tested strains. 
         Results: This study revealed the following findings:(1) PCR was positive in 63 subjects, 
including 58 high risk cases (77.3%) and 5 of controls (12.5%). (2) 17 high risk cases (24.6%) 
had false positive IgM and 5 of controls (12.5%) had false negative result for IgM. (3) 17 high 
risk cases (32.7%) had false positive IgG and 5 of controls (12.5%) had false negative IgG. (4) 
No significant association between eating raw meat or contact with cats and positive ELISA for 
PCR  but  there  is  highly  significant  association  between  women  with  contact  with  soil  and 
positive PCR. (5) No significant relation between residency and either ELISA or PCR.  (6) 
Significant negative correlation between the age of the studied women and positivity of PCR. 
         Conclusion:  this study highlights the need for a confirmatory test to detect primary acute 
toxoplasmosis in pregnant women. It demonstrates the possibility of defining and selecting the 
high-risk cases for mother-to-child transmission of infection by combining specific serology and 
PCR tests to formulate a specific approach 
         Key words : PCR , Toxoplasma gondii and Repeated abortion. 
 
Introduction 
 
         Primary  maternal  infection  during 
pregnancy  is  frequently  associated  with 
transmission of T.gondii to the fetus (Wong 
and  Remington,  1994).  Transplacental 
transmiission  of  Toxoplasma  from  an  
infected,  pregnant  women  to  the  unborn 
results  in  fetal    damage  to  a  degree 
depending  on  the  gestational  age  (kopecky 
et  al.,  2001).  Early  -  first    trimester 
maternal infections are less likely to result 
in congenital infection but the sequelae are 
more severe (Gagne, 2001).  
         Transplacental  passage  is  more 
common when maternal infection occurs in 
the latter half of pregnancy, but fetal injury 
is usually much less severe. It may lead to 
miscarriage, still birth, or congenital defects 
depending  on  the  stage  of  gestation  when 
the  infection  occurs    (Dubey  and  Beattie, 
1988).  Several  studies  have  suggested  its 
role  in  the  causation  of  abortion  
(Remington et al., 1995; Sahwi et al., 1995 
and  Zargar et al., 1999). 
         Although serological testing has been 
one of  the  major  diagnostic  techniques  for 
toxoplasmosis,  it  has  many  limations,  for 
example, it may fail to detect specific anti-
toxoplasma  immunoglobulin  G  (IgG)  or 
IgM  during  the  active  phase  of  T.gondii 
infection, because these antibodies may not 
be  produced  until  after  several  weeks  of 
parasitemia.  Therefore  the  high  risk  of 
congenital toxoplasmosis of a fetus may be  
undetected  because  the  pregnant  mother 
might test negative during the active phase 
of T.gondii infection. Several PCR – based 
techniques  (Lee  et  al.,  1999  and  Pujo- 
Rique  et  al.,  1999)  which  have  been 
developed for the diagnosis of Toxoplasma 
using  various  clinical  specimens,  including 
amniotic fluid (Costa et al., 1997; Hohlfeld 
et  al.,  1994),  blood  (Ho-yeh  et  al.,  1992; 
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Bergstrom  et  al.,  1998  and  Joss  et  al., 
1993),  cerebrospinal  fluid  (Roberts  et  al., 
2001),  and tissue  biopsy (Johnson et  al., 
1993). Among these techiques, nested PCR  
followed by hybridization of PCR products 
has been the most sensitive method. 
 
Material and Methods 
 
         This  study  was  reviewed  and 
approved  by  the  Mansoura    University  of 
science, and informed consent was obtained 
from all the study
 groups.
  
 
Study groups: 
Group I: 
Inclusion criteria: 
  Women  with  repeated  abortion  (≥2 
times). 
  Positive anti-Toxoplasma IgM or IgG. 
  Other  causes  of  repeated  abortion 
were excluded. 
  High risk of exposure to Toxoplasma. 
    This  group  comprised  75  cases 
selected  randomly  from  patients  attending 
Obstetric
  and  Gynecology  dapartment  at 
Mansoura University Hospital, complaining 
of repeated  abortions.  They  were  collected 
through one year from August 2006. Age of 
the patients ranged from 20-30 years (mean 
age 25.45±2.03).    
 
Group II (control group): 
         This  group  included  40  healthy 
females,  with  normal  pregnancy,  matched 
for  age,  residency  and  socioeconomic 
status.  Anti-Toxoplasma  IgM  or  IgG  was 
negative for all controls. 
 
Methods: 
DNA extraction 
PCR amplifications: 
Isolation of DNA.  
DNA  was  isolated  from  blood 
samples  using  a  commercial  purification
 
system (Wizard Genomic DNA Purification 
Kit;  Promega,  Madison,
 WI)  following  the 
manufacturer’s  instructions  for  DNA
 
purification  from  blood.  Final  pellets  were 
resuspended in 30
 µL of TE buffer (10 mM 
Tris, 1 mM EDTA, pH 7.2) and stored
 at –
20°C until used.
  
 
 
Nested PCR assay 
         The nested PCR was performed on all 
DNA  samples  to  amplify  a
 fragment  from 
the B1 gene, which is present in 35 copies 
and
 is  conserved  in  the  T.  gondii  genome, 
as described by (Burg et al., 1989). 
 
First cycle: 
         The primers used in the first round of 
the  PCR  (inner
  primers)  were  (5'-
GGAACTGCATCCGTTCATGAG-3'),and 
(5'-TCT-TTAAAGCGTTCGTGGTC-3'),
 
which  correspond  to  nucleotides  694–714 
and 887–868,
 respectively at 193 bp. 
 
Second cycle: 
         The primers used in the second round 
(outer  primers)
 were  (5'-TGCATAG  GTT-
GCAGTCACTG-3'  and  (5'-GGCGACC-
AATGTGC-GAATAGACC-3'),
  which 
correspond  to  nucleotides  757–776  and 
853–831,
 respectively at 96bp.
 
         Three  microliters  of  template  DNA 
were added to a  final volume
 of 50 µL  of 
PCR  mixture  consisting  of  5  µL  of  10
 x 
PCR buffer (50 mM Tris-HCl, pH 9.1, 3.5 
mM  MgCl2),  8  µL
  of  1.25  mM 
deoxynucleoside  triphosphates,  0.5  µL  of 
Taq
 DNA polymerase [5 units/µL], and 1.5 
µL (20 pmol)
 of each of the outer primers. 
The amplification was performed
 in Hypaid 
thermal cycler PCR. The cycling conditions 
for both PCRs were 95°C for
 five minutes, 
followed  by  30  cycles  at  94°C  for  30 
seconds,
 55°C for 90 seconds, and 72°C for 
one  minute,  and  a
 final  extension  at  72°C 
for 10 minutes.
  
-  Three  microliters  of  the  first-round 
product  were  used  as  template
  for  the 
second-round  PCR  in  a  total  volume  of 
50µL under
 the same conditions as in the 
first round, using the inner primers.
 DNA 
extracted  from  RH  strain  of  T.  gondii 
from  the  collection
  of  the  Service  de 
Parasitologie-Mycologie  (Grenoble, 
France)
 was  used  as  a  positive  control. 
The PCR mixture without DNA
 and with 
DNAase-free water were used as negative 
controls  to
  monitor  for  cross-
contaminations. 
-  One  negative  control  and  one  positive 
control  were  included
  for  every  23 
samples in each    PCR.  The positive 
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 controls  were
  loaded  last  to  avoid 
contamination of the sample. To guaranty
 
the reliability of the results and detect any 
possible  contamination,
 all  samples  were 
processed in duplicate. The test result was
 
considered positive if the amplified DNA 
fragment  was  clearly
  visible  in  both 
samples. 
-  Sample  cross-contamination  problems 
were  avoided  following  a
  number  of 
precautions including the use of  aerosol-
guarded tips,
 performing DNA extraction 
in  a  laminar  flow  hood  with  subsequent
 
irradiation  by  UV  light  and  the  use  of 
three  separate  areas
  for  the  DNA 
extraction,  preparation  of  PCR  mixture 
and a separate
 area for PCR amplification 
and  running  gels.  Five  microliters
 of  the 
PCR  product  were  subjected  to 
electrophoresis  on  a  1.2%
  agarose  gel 
stained  with  ethidium  bromide  (Burg  et 
al, 1989) . 
 
Statistical analysis: 
         Statistical  analysis  was  done  by 
computer  using  SPSS  version  10.0.  Our 
data  was  non-parametric.  Comparison 
between  various variables was done using 
Chi square (χ2) test (significant if p<0.05). 
Correlation  between  variables  was  done 
using sperman correlation. 
 
 
Results: 
 
Table(1): Demographic data of subjects included in this study: 
 
Controls 
(n=40) 
n(%) 
High risk cases (n=75) 
n(%)  Parameter 
 
32(80.0%) 
8(20.0%) 
24.15 
 
39(52.0%) 
36(48.0%) 
25.45 
Age(years) 
20-25(71) 
26-30(44) 
Mean age 
 
11(27.5%) 
15(37.5%) 
14(35.0%) 
 
16(21.3%) 
30(40.0%) 
29(38.7%) 
Time of samples 
First trimester(27) 
Second trimester(45) 
Third trimester(43) 
 
40(100.0%) 
None 
None 
 
0(0.0%) 
69(92.0%) 
6(8.0%) 
No. of abortion 
0(40) 
2(69) 
≥3(6) 
 
30(75.0%) 
10(25.0%) 
 
57(76.0%) 
18(24.0%) 
Residency 
Urban(87) 
Rural(28) 
 
9(22.5%) 
31(77.5%) 
 
23(30.7%) 
52(69.3%) 
Eating raw meat 
Yes(32) 
No(83) 
 
9(22.5%) 
31(77.5%) 
 
20(26.7%) 
55(73.3%) 
Contact with cats 
Yes(29) 
No(86) 
 
11(27.5%) 
29(72.5%) 
 
62(82.7%) 
13(17.3%) 
Contact with soil 
Yes(73) 
No(42) 
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Fig.(1) PCR results in high risk cases and control group PCR was positive in 58(77.3%) of 
cases and 5(12.5%) of controls with highly significant increase PCR positivity in 
patient compared with controls (p<0.001)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
fig (2) PCR positivity in relation to IgM results 17 cases (24.6%) had negative PCR result 
i.e. false positive and among 40 control with negative IgM, 5(12.5%) had positive 
PCR i.e. false negative result with a highly significant association between positive 
PCR and positive IgM (p=0.001).  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Fig (3) PCR positive in relation to IgG results Among 52 high risk cases positive IgG, 
17(32.7%) had negative PCR result i.e. false positive and among 40 control IgG, 
5(12.5%)  had  positive  PCR  result  i.e.  false  negative  with  highly  significant 
association between positive PCR and positive IgG (p=0.0001). 
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Fig (4) IgM and PCR result among high risk cases in relation to eating raw meat 
This  fig.  showed  no  significant  association  between  eating  raw  meat  and  positive  IgM 
(p>0.05)   and also  showed no significant association between eating raw meat and 
PCR (p>0.05) . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig (5) IgM and PCR result among high risk cases in relation to contact with cats.This Fig. 
showed  no  significant  association  between  contact  with  cats  and  positive  IgM 
(p>0.05) and also showed no significant association between contact with cats cases 
and positivity of PCR (p>0.05)  
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Fig (6) Toxoplasma gondii amplification DNA pattern Lane M  is DNA marker, Lane 1 is 
Negative control without DNA, Lane 2 is positive control for PCR, Lane 3 and 6 
are negative for PCR and Lane 4,5 and 7 are positive at 96 bp. 
 
 
Discussion 
 
         Precise  knowledge  of  acute  T.gondii 
infections  during  pregnancy  is  needed  for 
risk assessment of vertical transmission of 
infections  as  basis  for  counselings, 
prevention, and treatment (Vimercati et al., 
2000).  Fetal  toxoplasmosis  remains  a 
significant  disease  as  a  result  of  acute 
parasitic infection in mothers not previously 
infected,  consequences  of  infection  are 
most  severe  if  it  occurs  during  the  first 
trimester (Desmonts et al., 1985 and Daffos 
et al., 1998). 
         Toxoplasmosis  can  lead  to  a  single 
pregnancy loss, and there are no confirmed 
studies  to  suggest  that  specific  infections 
will  lead  to  recurrent  pregnancy  loss  in 
humans (Summers, 1994 and Regan et al., 
2001).  However,  our  cases  were  charact-
erized  by  repeated  abortion(≥2  pregnancy 
loss), this bad outcome is considered to be a 
risk factor for toxoplasmosis and repeated 
infection  with  T.gondii  during  pregnancy 
may explain this bad outcome, Table (1).  
         In the current study primary diagnosis 
of T.gondii infection in pregnant women at 
high  risk  (bad  outcome,  history  of  eating 
raw  meat,  contact  with  cats  and  contact 
with  soil),  depended  on  serological 
diagnosis  with  either  positive  anti-
toxoplasma  IgG  or  IgM.  Although 
serological  testing  has  been  the  major 
diagnostic technique of toxoplasmosis it has 
many  limitations  because  false  positive 
results  have  been  reported  by  other 
investigators  (Hofgartner  et  al.,  1997  and 
Wilson et al., 1997), in addition to the false 
negativity that may occur during the active 
phase  of  T.gondii  infections  (Lee  et  al., 
1999 ), Table (1). 
         This study was conducted to test the 
utility of polymerase chain reaction (PCR) 
assay  to  detect  recent  infections  with 
T.gondii in pregnant women. T.gondii DNA 
was detected by using B1 gene as a target 
for  amplification  which  is  highly  specific 
for T.gondii and is  well conserved among 
all of the tested strains (Burg et al., 1989). 
         Seventy  five  women  with  high-risk 
pregnancies  who  had  abnormal  pregnancy 
outcome and positive specific antibodies for 
Toxoplasma (cases) and forty women with 
normal pregnancy (controls) were tested for 
the presence of Toxoplasma DNA in their 
blood by a nested PCR. 
         The  present  study  revealed  the 
following findings:(1) PCR was positive in PCR detection of Toxoplasma gondii DNA versus serological…….  
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63  subjects,  including  58  high  risk  cases 
(77.3%) and 5 of controls (12.5%), Figs (1), 
(2) showed that 17 high risk cases (24.6%) 
had  false  positive  IgM  and  5  of  controls 
(12.5%) had false negative result for IgM, 
Figs (2), (3) showed that 17 high risk cases 
(32.7%)  had  false  positive  IgG  and  5  of 
controls  (12.5%)  had  false  negative  IgG, 
Figs  (3),  (4)  showed  no  significant 
association  between  eating  raw  meat  or 
contact  with  cats  and  positive  ELISA  or 
PCR,  Fig.(4)  detected  highly  significant 
association  between  women  with  contact 
with  soil  and  positive  PCR,  Fig.(5). 
recoreded  no  significant  relation  between 
residency and either ELISA or PCR.  
         In  Jordan,  twenty  (13.5%)  women 
with
  abnormal  pregnancy  outcomes 
compared  with  none  in  the  control
  group 
were  identified  to  be  possibly  infected 
during  the  current
  pregnancy  (e.g.,  recent 
infection) based on the combined results
 of 
a positive IgG ELISA result (four were also 
positive  for
  IgM),  and  the  detection  of 
Toxoplasma  DNA  by  a  PCR  assay.  They
 
were  seronegative  in  the  previous 
pregnancy. The negative results
 obtained by 
both  the  PCR  and  serology  rule  out  an 
infection
  in  the  rest  of  women  in  both 
groups.
 Previous studies confirmed that the 
PCR  could  actually  detect
  T.  gondii  in 
blood  specimens  of  women  before  or 
during pregnancy (Hussein et al., 2002 and 
EL-Awady et al., 2000). 
         A  previous  study  of  serial  blood 
samples  from  acutely  infected
  pregnant 
women  indicated  that  in  the  presence  of 
toxoplasma-specific
  IgG  and  IgM 
antibodies, and the additional presence of a 
high
 dye test titer were insufficient criteria 
for identifying toxoplasma
 infection in early 
pregnancy  because  some  acute  infections 
will
  not  be  detected  (Jenum  et  al.,  1997). 
Conversely,  some  women  will  be  falsely 
identified
  as  being  infected,  (Liesenfeld  et 
al.,  2001)  and  undergo  unnecessary 
diagnostic  amniocentesis
  and  antiparasitic 
treatment (Jenum et al., 1997). In a study of 
uterine  Toxoplasma
  infections  in  women 
with  repeated  abortions,  five  (71.4%)  of
 
seven  toxoplasma-positive  endometrium 
patients were serologically
 negative. These 
reports  emphasize  the  importance  of 
confirmatory
  testing  (Stray-Pedersen  and 
Lorentzen, 1977). 
        In  the  current  study,  the  risk  factor 
strongly associated with acute infection in 
PCR-positive  women  is  contact  with  soil, 
although eating raw meats and contact with 
cats are also associated risk factors. Nimri 
et  al.  (2004)  found  that  the  risk  factors 
strongly associated with acute infection in 
the IgG-positive and PCR-positive women 
were eating raw meat and contact with soil. 
         Moreover, Cook et al. (2000) reported 
that risk factors most strongly predictive of 
acute  infection  in  pregnant  women  were 
eating undercooked lamb, beef or game and 
contact with soil, and that contact with cats 
was not a risk factor. They also concluded 
that  preventive  strategy  should  aim  to 
reduce  prevalence  of  infection  in  meat, 
improve  labelling  of  meat  according  to 
farming  and  processing  methods  and 
improve  quality and consistency  of  health 
information given to pregnant women. 
         Similar to The present study, Jenum et 
al.  (1998)  reported  that  the  incidence  of 
T.gondii  for  women  living  in  urban  areas 
was  not  significantly  different  from  that  
living in rural areas. 
         In the present study, among 63 PCR 
positive  pregnancy  women,  48  of  them 
were  living  in  urban  area  with  no 
significant association between residence of 
the studied  groups and positivity  of PCR. 
However, the high frequency of cases living 
in urban area may be related to exposure to 
risk  factors  in  urban  area  as  eating  raw 
meats as well as contact with cats. 
         As regards the age of pregnant women 
with  T.gondii;  our  study  showed  a 
significant negative correlation between the 
age and the positivity of PCR. This means 
that  infection  with  T.gondii  is  more 
frequent in  young pregnant women (mean 
age  25.45±2.03  years).  This  can  be 
explained by the fact that the child-bearing 
period starts after marriage  with  desire  of 
having  offspring  early,  in  addition  to 
exposure  to  risk  factors  is  more  common 
among young women. 
         As  soon  as  the  primary  maternal 
T.gondii  infection  was  confirmed,  the 
women  was  counseled  by  one  of  the 
investigators. An ultrasound examination of 
the  fetus  was  performed,  and  the  women 
was  offered  amniocentesis,  performed  as 
soon as possible but no earlier than the 12
th 
week  of  gestation  (Desmonts  et  al.,  1985 Abo EL Naga et al   
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and  Jenum  et  al.,  1998).  Antiparasitic 
treatment including spiramycin (before the 
18
th  week  of  gestation)  and/or 
pyrimethamine,  sulfonamide,  and  folinic 
acid  (after  the  18
th  week  of  gestation) 
according  to  published  guidelines  was 
recommended  for  all  women  (Stray-
Pedersen, 1993). 
 
        In  conclusion:  this  study  highlights 
the  need  for  a  confirmatory  test  to  detect 
primary  acute  toxoplasmosis  in  pregnant 
women.  It  demonstrates  the  possibility  of 
defining  and  selecting  the  high-risk  cases 
for  mother-to-child  transmission  of  infec-
tion  by  combining  specific  serology  and 
PCR tests to formulate a specific approach. 
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 ـب يدىنىج امزلابىسكتلل ٌوىنلا ضمحلا صُخشت PCR  
رمتسملا ضاهجلإا يور ءاسنلا ٍف ٍجىلورُسلا صُخشتلاب تنراقملاب 
 
 ذمحم نامَإ ،زابلا ذمحأ قزر ،ثىتلش ًلع ًلع ،اجنلا ىبأ ذمحم ةرىمأ
ضاُف 
 ٌإٍحنا ىهع ىسق –    وٕهعنا تٍهك - صًُنا تعيبج  ةسٕ -   شصي  
 
 
 
           ٍي تقفإي زخأ ىحٔ ةسٕصًُنا ّعيبج وٕهعنا تٍهك ًف تساسذنا ِزْ جٌشجأ ذقن
تساسذنا محي ثلابحنا عًٍج  ,  سبٍخخا ىح 57    ًخنا ثلابحنا ٍي تٍئإشع تقٌشطب ِذٍس
سُنا ىسقب ذجٕح ءب   ذٍنٕخنأ    ضبٓجلإا ٍي ٌَٕبعٌ ٌٍزنأ ًعيبجنا ةسٕصًُنا ىفشخسًب
اضٍنلإن ٍّببجٌإ جئبخَ دٕجٔ عي  سشكخًنا  ,  شٓش ٍي وبع للاخ ًف ثلابحنا جعًج 8    وبع
6002  .   ٍي  حٔاشخٌ  ثلابحنا  شًع 60 - 00     سبًعلأا  طسٕخئ  ُّس 67.57 ± 6.00  
  ىنإ  تفبظلإبب 50   هع  تساسذنا  جٌشجأٔ  ّطببظ  تعًٕجًك  ًعٍبط  مًحب  ِذٍس  ى
ئُٕنا طًحنا      ة ثلابحنا ود ٍي صهخخسًنا .Nested PCR  
  ذددٓحٔ  تددساسذنا ِزدددْ ا ىدددنإ  واذخخدددسإ تددٍَبكيإ سبدددبخخ PCR    تددد ٌذحنا تببدددبلإا ذددٌذحخن
ميإحنا ثاذٍسنا ًف بيصلابٕسكخنبب  ,  واذخخدسبب بيصلابٕدسكخهن ئٕدُنا طًحنا ذٌذحح ىح
 ٍٍج B1    يادَٕٕج بيصلابٕسكخنا صخح ًخنأ شٍبكخهن  ذٓك  .  تساسذنا كهح للاخ ٍئ
تٍنبخنا جئبخُنا ىنإ بُهبٕح :  
-   20    إَبك تنبح PCR    +ve  , 78    ٔ تببصًنا ثلابحنا ٍي تنبح 7   لٔشخُكنا ىف ثلابح .  
-   75   ( 65.2  )%  ـن تبربك تٍببجٌإ إَبك تببصًنا ثلابحنا ٍي تنبح IgM   7    لٔشخُكنا ىف
 إَبك    ـن تبربك تٍبهس IgM  .  
-   75 ( 06.5  )% لابحنا ٍي تنبح إَبك تببصًنا ث    ـن تبربك تٍببجٌإ IgG   7    لٔشخُكنا ىف
 ـن تبربك تٍبهس إَبك IgG .  
-    ٔ ططقنبب لبصحلاأ تئٍُنا تًحهنا مكأ ٍٍب  تٍئبصحإ تنلاد ثار تقلاع يأ ذجٕح لا
تٍببجٌإ     اضٍنلإن  PCR    ٔ تبشخنبب لبصحلاا ٍٍب  تٍئبصحإ تنلاد ثار تقلاع ذجٕح  ٍكنٔ
 ـنا تٍببجٌإ .PCR  
-   ٕح لا  جئبخَٔ تشٍعًنا ٌبكي ٍٍب  تٍئبصحإ تنلاد ثار تقلاع ذج     PCR    اضٍنلإا ٔأ .  
-    تساسذنا محي ميإحنا ثاذٍسنا شًع ٍٍب تٍئبصحإ تنلاد ٔر ًبهس طببحسا ذجٌٕ
 ـنا  تٍببجٌإٔ .PCR     
 
 